January 2024

SAN DIEGO, Jan. 7, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it has entered into a five-year distributor partnership with CrossLink Life Sciences, LLC to expand the sales network supporting ZYNRELEF® (bupivacain

NEW YORK, Jan. 7, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) between February 26, 2021 and June 13, 2023, both dates inclusive (the “Class Peri

NEW YORK, Jan. 7, 2024 /PRNewswire/ — The US Courseware Market is estimated to grow by USD 1.06 billion, accelerating at a CAGR of 5.42% during the forecast period. The US Courseware Market is fragmented owing to the presence of many global and regional companies. A few prominent companies th

NEW YORK, Jan. 7, 2024 /PRNewswire/ — The Asia-Pacific (APAC) Automotive Wiring Harness Market size is estimated to grow by USD 6.59 billion from 2022 to 2027, growing at a CAGR of 4.88%. The Asia-Pacific (APAC) Automotive Wiring Harness Market is fragmented owing to the presence of many glo

NEW YORK, Jan. 7, 2024 /PRNewswire/ — The Automotive Service Market is estimated to grow by USD 351.69 billion, accelerating at a CAGR of 7.65%. The Automotive Service Market is fragmented owing to the presence of many global and regional companies. A few prominent companies that offer Automo

Agreement between Ascendis Pharma A/S and ST is for the exclusive distribution and commercialisation of three Ascendis Pharma endocrinology therapiesTwo of the therapies are already internationally approved, the third is in development following successful Phase 2 dataST’s exclusive distribut

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: